RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders

The newly published charter widens the required expertise to become an ACIP member and stresses vaccine safety. Elsewhere, Gilead licensed a Kymera drug and a new RNA-focused startup emerged.